FIP1L1-PDGFRα D842V, a Novel Panresistant Mutant, Emerging After Treatment of FIP1L1-PDGFRα T674I Eosinophilic Leukemia With Single Agent Sorafenib
Leukemia - United Kingdom
doi 10.1038/leu.2009.2
Full Text
Open PDFAbstract
Available in full text
Date
February 12, 2009
Authors
Publisher
Springer Science and Business Media LLC